FREQUENCY OF LMS AND TVD IN TYPE 2 DIABETIC ADULTS VS NON-DIABETICS IN CAD POPULATION OF PAKISTAN
Main Article Content
Keywords
CAD, Triple vessel CAD, Double vessel CAD, Single vessel CAD, Coronary artery
Abstract
Objective: The current study aimed to compare the prevalence of left central stem disease and triple vessel disease in coronary artery (CAD) patients with and without type 2 diabetes.
Study Design: Cross-sectional study
Research Setting and Duration: The study was conducted at the cardiology department, Lady Reading Hospital, Peshawar, from 6th June 2022 to 26th December 2022.
Methods: In this study, 155 patients diagnosed of having CAD were identified. In all the patients, coronary angiography was performed to evaluate the status of the coronaries. Patients with occlusion of LAD, RCA, and LCX on angiography were considered to have triple vessel disease and LMS occlusion was consider as a separate entity.
Results of the study: The patients' ages ranged from 40 to 70 years. The mean age was 59.3±12.3 years. Male to female ratio was 3:1. Out of the 155 participants, 65 (41.9%) were diabetic, and 92 (59.4%) were hypertensive. As per the number of vessels obstructed, 37(23.87%) patients had single-vessel CAD, 47(30.32%) had double-vessel CAD, and 71(45.81%) had triple-vessel CAD. There were a total of 15 (9.68%) LMS cases, out of which 8(5.33%) were diabetic patients, and 7(4.52%) were nondiabetic patients. There was a significant association found between diabetes and TVD.
Conclusion: In CAD patients, there is a high prevalence of triple vessel coronary artery disease, and diabetic patients are more prone to have TVD than non-diabetic patients.
References
2. Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology. 2019;234(10):16812-23. https://doi.org/10.1002/jcp.28350
3. Farooq MU, Iqbal Haider MM, Satti KN, Ahmed S, Ehtizaz M. Association of Severity of Coronary Artery Disease and HbA1c Levels in Patients with Acute Coronary Syndrome. Journal of Sharif Medical & Dental College.27.
4. Adil M, Khan I, Hassan Z, Habib SA, Jibran MS, Nawaz Sr T. One year outcomes after percutaneous coronary intervention in diabetics with stable ischemic heart disease: a single-center comparative study. Cureus. 2021;13(1). 10.7759/cureus.12731
5. Rathmann W, Giani G. Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030: Response to Wild et al. Diabetes care. 2004;27(10):2568-9. https://doi.org/10.2337/diacare.27.10.2568
6. Khan FR, Ali J, Ullah R, Hassan Z, Khattak S, Lakhta G, et al. Relationship between high glycated haemoglobin and severity of coronary artery disease in type II diabetic patients hospitalized with the acute coronary syndrome. Cureus. 2021;13(3). 10.7759/cureus.13734
7. Bhar-Amato J, Davies W, Agarwal S. Ventricular arrhythmia after acute myocardial infarction:‘the perfect storm’. Arrhythmia & electrophysiology review. 2017;6(3):134. 10.15420/aer.2017.24.1
8. Ahmed B, Manzoor V, Hussain S, Hussain W, Jamil A, Shaikh L, et al. Frequency of Triple Vessel Coronary Artery Disease in Diabetic and Non Diabetic Patients Presenting with NSTEMI: Frequency of Triple Vessel Coronary Artery Disease in Diabetic and Non-Diabetic Patients. Pakistan Journal of Health Sciences. 2022:98-102. https://doi.org/10.54393/pjhs.v3i06.221
9. Sulehria SB, Wajid H, Wasae A, Asghar A, Shahid MA, Tahir M. To determine the frequency of triple vessel coronary artery disease in patients admitted with acute coronary syndrome. The Professional Medical Journal. 2024;31(05):726-32. https://doi.org/10.29309/TPMJ/2024.31.05.8055
10. Ja B. Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction. Circulation. 2003;108:814-9.
11. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. Journal of the American college of cardiology. 2006;48(1):1-11. https://doi.org/10.1016/j.jacc.2006.02.056
12. Birnbaum Y, Rankinen J, Jneid H, Atar D, Nikus K. The role of ECG in the diagnosis and risk stratification of acute coronary syndromes: an old but indispensable tool. Current cardiology reports. 2022;24(2):109-18. https://doi.org/10.1007/s11886-021-01628-7
13. Li Q, Yuan D, Zeng G, Jiang L, Xu L, Xu J, et al. The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort study. Diabetes Research and Clinical Practice. 2024:111751. https://doi.org/10.1016/j.diabres.2024.111751
14. Bhagat JM, Dhanvij B, Telrandhe S, Sudame BS. Case report on coronary artery disease with TVD (Triple Vessel Disease). 2021.
15. Bhalli MA, Khan MQ, Samore NA, Mehreen S. Frequency and clinical outcome in conduction defects in acute myocardial infarction. Journal of Ayub Medical College Abbottabad. 2009;21(3):32-7.
16. Liang B, Gu N. Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose? Cardiovascular Diabetology. 2021;20(1):42. https://doi.org/10.1186/s12933-021-01241-6
17. Jennings R, Ganote CE. Structural changes in myocardium during acute ischemia. Circulation research. 1974;35(3_supplement):III-156-III-72. https://doi.org/10.1161/res.35.3_supplement.iii-156
18. Zhang Y, Guo L, Zhu H, Jiang L, Xu L, Wang D, et al. Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome. Cardiovascular Diabetology. 2024;23(1):143. https://doi.org/10.1186/s12933-024-02220-3